Skip to main content

Clinical Evaluation of Treatment with Ciprofloxacin

  • Chapter
Ciprofloxacin

Part of the book series: Current Topics in Infectious Diseases and Clinical Microbiology ((CTIDCM,volume 1))

  • 62 Accesses

Abstract

Ciprofloxacin is a 6-fluoroquinolone possessing a broad spectrum of activity and high potency (1, 2). Its pharmacokinetic behaviour suggests it should prove suitable for treatment of systemic and urinary tract infections (3, 4). We evaluated this agent in the treatment of adults with a variety of common clinical infections in an attempt to define its efficacy and safety in an adult population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.

    Article  PubMed  CAS  Google Scholar 

  2. Hoogkamp-Korstanje, J. A. A.: Comparative in vitro activity of five quinolone derivatives and five other antimicrobial agents used in oral therapy. European Journal of Clinical Microbiology 1984, 3: 333–338.

    Article  PubMed  CAS  Google Scholar 

  3. Wingender, W., Graefe, K., II., Gau, W., Forster, D., Beermann, D., Schacht, P.: Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. European Journal of Clinical Microbiology 1984, 3: 355–359.

    Article  PubMed  CAS  Google Scholar 

  4. Wise, R., Lockley, M. R., Crump, B., Adhami, Z. N.: The parmacokinetics and tissue penetration of orally administered enoxacin, norfloxacin and ciprofloxacin. Research and Clinical Forums 1985, 7: 63–68.

    CAS  Google Scholar 

  5. Medical Research Council: Definition — classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965, 1: 776.

    Google Scholar 

  6. Chapman, S. T., Speller, D. C. E., Reeves, D. S.: Resistance to ciprofloxacin. Lancet 1985, 11: 39.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

H. C. Neu D. S. Reeves

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Finch, R., Whitby, M., Craddock, C., Holliday, A., Martin, J., Pilkington, R. (1986). Clinical Evaluation of Treatment with Ciprofloxacin. In: Neu, H.C., Reeves, D.S. (eds) Ciprofloxacin. Current Topics in Infectious Diseases and Clinical Microbiology, vol 1. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01930-5_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-01930-5_39

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-663-01931-2

  • Online ISBN: 978-3-663-01930-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics